This inventor holds 1 USPTO granted patent. Top assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.l.a.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Zhixia Yang: Innovator in Bone Metabolism Treatments
Introduction
Zhixia Yang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly in the development of innovative treatments for bone metabolism disorders.
Latest Patents
Zhixia Yang holds 1 patent for his invention titled "Site-specific pegylated linear salmon calcitonin analogues." This invention relates to site-specific PEGylated linear salmon calcitonin analogs, or pharmaceutically acceptable salts thereof. The patent outlines a process for their preparation, pharmaceutical compositions comprising them, and their use for the preparation of a medicament aimed at treating or preventing diseases associated with bone metabolism, such as osteoporosis.
Career Highlights
Zhixia Yang is affiliated with the Institute of Pharmacology and Toxicology at the Academy of Military Medical Sciences. His work focuses on advancing medical treatments that address critical health issues related to bone health.
Collaborations
Zhixia Yang has collaborated with notable colleagues, including Keliang Liu and Jiankun Qie, to further enhance research and development in his field.
Conclusion
Zhixia Yang's innovative work in the area of bone metabolism treatments exemplifies the impact of dedicated research and invention in improving health outcomes. His contributions are vital in the ongoing fight against osteoporosis and similar conditions.